GlassScriptPhysician profile
Mohsen Davoudi
NPI 1649472317
$10,894.13
in general payments reported to CMS, 2019-2025
10 companies · $3,032 in 2025
The $3,032 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2021: $12.00 · 2022: $119 · 2023: $5,788 · 2024: $1,696 · 2025: $3,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,479 · Food and Beverage: $2,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,479.24 |
| Food and Beverage | $2,036.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noah Medical Corporation | $6,205.11 | 2023-2025 | Galaxy |
| Intuitive Surgical, INC. | $2,734.13 | 2023-2025 | Da Vinci Surgical System |
| Pulmonx Corporation | $1,261.99 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Galvanize Therapeutics, INC | $314.39 | 2023-2025 | Aliya System |
| Becton, Dickinson and Company | $152.23 | 2019 | |
| Veran Medical Technologies, INC. | $95.58 | 2019 | |
| Shionogi INC | $51.28 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $33.71 | 2022 | |
| Amgen INC. | $33.71 | 2022 | |
| Paratek Pharmaceuticals, INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohsen Davoudi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.